ASO Author Reflections: Racial Disparities in Chemoresponsivity in Localized Pancreatic Cancer: Nature or Nurture?

[1] Nickens H(1986)Report of the Secretary's Task Force on Black and Minority Health: a summary and a presentation of health data with regard to blacks J Natl Med Assoc. 78 577-580

[2] Madnick D(2020)Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients J Gastrointest Oncol. 11 633-643

[3] Handorf E(2020)Association of treatment inequity and ancestry with pancreatic ductal adenocarcinoma survival JAMA Surg. 155 e195047-345

[4] Ortiz A(2016)Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer JAMA Surg. 151 338-939

[5] Heller DR(2021)Surgical eligibility does not imply surgical equity: recommendations for curative treatment in patients with stage I/II pancreatic head adenocarcinoma differ by age and race Ann Surg. 116 930-1677

[6] Nicolson NG(2010)Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process Cancer. 76 1671-540

[7] Ahuja N(1995)The National Cancer Data Base report on pancreatic cancer Cancer. 3 532-33

[8] Khan S(2019)Disparities in pancreatic cancer treatment and outcomes Health Equity. 72 7-1615

[9] Kunstman JW(2022)Cancer statistics, 2022 CA Cancer J Clin. 98 1608-undefined

[10] Shapiro M(2022)Racial disparity in pathologic response following neoadjuvant chemotherapy in resected pancreatic cancer: a multi-institutional analysis from the central pancreatic consortium Ann Surg Oncol. undefined undefined-undefined

[1] Nickens H(1986)Report of the Secretary's Task Force on Black and Minority Health: a summary and a presentation of health data with regard to blacks J Natl Med Assoc. 78 577-580

[2] Madnick D(2020)Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients J Gastrointest Oncol. 11 633-643

[3] Handorf E(2020)Association of treatment inequity and ancestry with pancreatic ductal adenocarcinoma survival JAMA Surg. 155 e195047-345

[4] Ortiz A(2016)Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer JAMA Surg. 151 338-939

[5] Heller DR(2021)Surgical eligibility does not imply surgical equity: recommendations for curative treatment in patients with stage I/II pancreatic head adenocarcinoma differ by age and race Ann Surg. 116 930-1677

[6] Nicolson NG(2010)Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process Cancer. 76 1671-540

[7] Ahuja N(1995)The National Cancer Data Base report on pancreatic cancer Cancer. 3 532-33

[8] Khan S(2019)Disparities in pancreatic cancer treatment and outcomes Health Equity. 72 7-1615

[9] Kunstman JW(2022)Cancer statistics, 2022 CA Cancer J Clin. 98 1608-undefined

[10] Shapiro M(2022)Racial disparity in pathologic response following neoadjuvant chemotherapy in resected pancreatic cancer: a multi-institutional analysis from the central pancreatic consortium Ann Surg Oncol. undefined undefined-undefined